Whereas all medicine offered to American shoppers face a rigorous approval course of, that is not the case relating to dietary supplements. The Meals and Drug Administration (FDA) doesn’t approve dietary supplements, and whereas there are some limits to the claims that may be made by corporations on this area, there is a truthful quantity of latitude.
“The producer will need to have substantiation that the declare is truthful and never deceptive and should submit a notification with the textual content of the declare to FDA no later than 30 days after advertising and marketing the dietary complement with the declare. If a dietary complement label consists of such a declare, it should state in a ‘disclaimer’ that FDA has not evaluated the declare,” in keeping with the FDA web site.
Complement makers could make sure construction/perform claims with out FDA preapproval, so long as they’ve substantiation that the claims are truthful and never deceptive, and that they meet the company’s different necessities.
“The disclaimer should additionally state that the dietary complement product is just not meant to ‘diagnose, deal with, remedy or stop any illness,’ as a result of solely a drug can legally make such a declare,” the federal company shared.
It is a authorized gray space that permits dietary supplements to promote that they may also help with health, hair development, sleep, and your potential to focus.
Synergy CHC Corp., the maker of Focus Issue, which is described on its Amazon gross sales web page as a “Mind Complement for Reminiscence, Focus and Focus,” has filed for Chapter 11 chapter.
Focus Issue has been a bestseller
Synergy makes some daring claims about what Focus Issue can do for shoppers.
Focus Issue Further Energy mind dietary supplements comprise a strong mixture of nutritional vitamins, minerals, and neuro-nutrients that not solely energy your mind however can even exchange your day by day multivitamin,” it shared.
The corporate, on Amazon, additionally stated that the complement promotes focus and reminiscence.
“Like different elements of your physique, your mind wants correct diet to carry out its greatest. This superior method improves and enhances reminiscence, focus, and your potential to focus,” it added.
Synergy CHC backs that up with the next declare that does not straight communicate to efficacy.
“Focus Issue is the #1 Pharmacist Really useful Model primarily based on the outcomes of the U.S. Pharmacy Instances Survey of Pharmacists’ OTC Suggestions for ‘Reminiscence Help’ dietary complement, 2025-2026,” the corporate shared.
Synergy CHC Corp. develops and markets shopper well being and wellness merchandise, led by its flagship manufacturers Focus Issue and Flat Tummy.
“Focus Issue, a clinically studied mind well being complement and purposeful beverage line with a 25-year legacy, enjoys established distribution within the U.S., Canada, and Mexico via main retailers together with Walmart, Amazon, BJ’s, and Walgreens, amongst others. Flat Tummy enhances Synergy’s portfolio as a life-style model targeted on ladies’s wellness and weight administration,” the corporate shared in a press launch.
Focus Issue maker misplaced its Costco deal
Synergy CHC warned of potential important monetary issues after it acquired discover from Costco that the warehouse membership can be dropping the corporate’s merchandise.
“On July 15, 2026, Costco Wholesale Company knowledgeable Synergy CHC Corp. that Costco will discontinue carrying the Firm’s Focus Issue merchandise. Costco has been a big buyer of the Firm for greater than 16 years,” it shared in an SEC submitting.
Extra Retail:
It is essential to notice that Costco didn’t share a cause for dropping Synergy CHC’s manufacturers.
“Costco accounted for roughly 58% of the Firm’s internet income in the course of the fiscal yr ended December 31, 2025. The Firm expects Costco’s resolution to have a fabric hostile impact on the Firm’s enterprise, outcomes of operations, liquidity, and monetary situation and is evaluating accessible financing and different strategic alternate options,” the submitting continued.
Costco nonetheless sells dietary supplements and purposeful drinks
Costco continues to promote different complement manufacturers and lately added Hiyo, a drink line that falls into the purposeful beverage area.
“Made with natural adaptogens, pure nootropics, and purposeful botanicals, every can provides what the model calls a ‘mood-enhancing, stress-relieving carry,’ or ‘the float,’ in keeping with a press launch.
The U.S. Meals and Drug Administration regulates elements and requires drink labels to be truthful, and the Federal Commerce Fee can step in if corporations make false claims.
“Useful beverage makers typically make much less particular claims, and the science behind them is usually inconclusive. SkinTe, a glowing tea, says it ‘helps pores and skin hydration and elasticity’ with 3,000 milligrams of collagen in a 12-ounce can. However final yr, Harvard Medical Faculty researchers stated there’s not but stable proof that collagen drinks or dietary supplements improve pores and skin, hair, or nail development,” in keeping with The Chicago Solar-Instances.
Useful drinks are a rising class.Shutterstock
Synergy CHC Chapter 11 chapter at a look
Synergy CHC Corp., the shopper healthcare firm, publicly traded as SNYR, filed Chapter 11 on Sept. 4, 2026, within the U.S. Chapter Courtroom for the District of Columbia, case 26-00465.
Its petition identifies its DBAs as Synergy Strips Corp. and Focus Issue Diet Labs.
Headquarters: Sebago, Maine
Belongings: $1 million to $10 million
Liabilities: $10 million to $50 million
Collectors: 1-49
Companies/manufacturers listed on the petition: Synergy Strips Corp., Focus Issue, and Issue Diet Labs.
Synergy Reorg, LLC, which occurs to share the Synergy title, additionally filed for Chapter 11 chapter on Sept. 4. Regardless of the same title, the 2 instances don’t seem like related.
Synergy CHC Corp. acquired a discover from The Nasdaq Inventory Market on August 20 indicating that the corporate is just not in compliance with Nasdaq Itemizing Rule 5250(c)(1) because of the delayed submitting of its Quarterly Report on Type 10-Q for the quarter ended June 30, 2026 with the Securities and Trade Fee (the “SEC”).
The Itemizing Rule requires corporations with securities listed on Nasdaq to well timed file all required periodic studies with the SEC.
That discover led to the agent of the corporate’s lender, ACP Company, LLC, sending CHC an Acceleration Discover.
“The Acceleration Discover states that, following the Occasions of Default beforehand disclosed by the corporate in its Present Report on Type 8-Okay filed on August 11, 2026, ACP, on the course of the required lenders, has exercised treatments underneath the Credit score Settlement,” in keeping with an SEC submitting.
That discover signifies that CHC’s lenders will not prolong the corporate any extra credit score and wish to be repaid in full.
“The Acceleration Discover additional states that, as of August 21, 2026, roughly $18.9 million was instantly due and payable underneath the Credit score Settlement and associated mortgage paperwork, unique of further curiosity, charges, prices and bills that proceed to accrue,” the submitting continued.
CHC Synergy continues to function underneath its Chapter 11 chapter submitting. The corporate has not shared it plans going ahead.
